End-of-day quote
Shanghai S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
20.62
CNY
|
+0.10%
|
|
+7.79%
|
-15.84%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,045
|
13,491
|
11,564
|
10,059
|
6,477
|
5,451
|
-
|
-
|
Enterprise Value (EV)
1 |
3,045
|
13,491
|
11,564
|
10,059
|
6,477
|
5,451
|
5,451
|
5,451
|
P/E ratio
|
19.6
x
|
5
x
|
19.5
x
|
13.3
x
|
33.1
x
|
11.4
x
|
8.97
x
|
-
|
Yield
|
-
|
3.68%
|
1.17%
|
1.97%
|
2.04%
|
2.18%
|
2.81%
|
-
|
Capitalization / Revenue
|
-
|
1.3
x
|
2.27
x
|
1.64
x
|
1.57
x
|
1.15
x
|
0.97
x
|
-
|
EV / Revenue
|
-
|
1.3
x
|
2.27
x
|
1.64
x
|
1.57
x
|
1.15
x
|
0.97
x
|
-
|
EV / EBITDA
|
-
|
-
|
-
|
10,066,261
x
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-48.1
x
|
-25.7
x
|
-839
x
|
53.8
x
|
FCF Yield
|
-
|
-
|
-
|
-
|
-2.08%
|
-3.88%
|
-0.12%
|
1.86%
|
Price to Book
|
-
|
3.4
x
|
2.84
x
|
1.63
x
|
1.22
x
|
0.92
x
|
0.85
x
|
-
|
Nbr of stocks (in thousands)
|
196,000
|
215,748
|
225,105
|
264,351
|
264,351
|
264,351
|
-
|
-
|
Reference price
2 |
15.54
|
62.53
|
51.37
|
38.05
|
24.50
|
20.62
|
20.62
|
20.62
|
Announcement Date
|
4/29/20
|
4/27/21
|
3/29/22
|
4/25/23
|
4/26/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
10,399
|
5,092
|
6,138
|
4,127
|
4,740
|
5,630
|
-
|
EBITDA
|
-
|
-
|
-
|
999.2
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
3,537
|
822
|
812.8
|
225.9
|
552
|
700
|
-
|
Operating Margin
|
-
|
34.01%
|
16.14%
|
13.24%
|
5.47%
|
11.65%
|
12.43%
|
-
|
Earnings before Tax (EBT)
1 |
-
|
3,533
|
819.9
|
801.7
|
218.9
|
546
|
692
|
-
|
Net income
1 |
156.9
|
2,549
|
595.9
|
681.1
|
198.4
|
480
|
610
|
-
|
Net margin
|
-
|
24.52%
|
11.7%
|
11.1%
|
4.81%
|
10.13%
|
10.83%
|
-
|
EPS
2 |
0.7929
|
12.50
|
2.630
|
2.870
|
0.7400
|
1.810
|
2.300
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-134.5
|
-211.7
|
-6.5
|
101.3
|
FCF margin
|
-
|
-
|
-
|
-
|
-3.26%
|
-4.47%
|
-0.12%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
2.300
|
0.6000
|
0.7500
|
0.5000
|
0.4500
|
0.5800
|
-
|
Announcement Date
|
4/29/20
|
4/27/21
|
3/29/22
|
4/25/23
|
4/26/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
-
|
-135
|
-212
|
-6.5
|
101
|
ROE (net income / shareholders' equity)
|
-
|
94.9%
|
16.2%
|
14.2%
|
3.6%
|
8%
|
9%
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
9.51%
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
7,159
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
18.40
|
18.10
|
23.40
|
20.10
|
22.50
|
24.30
|
-
|
Cash Flow per Share
|
-
|
13.70
|
-
|
5.250
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
1,093
|
689
|
745
|
587
|
913
|
1,004
|
1,004
|
Capex / Sales
|
-
|
10.51%
|
13.53%
|
12.13%
|
14.21%
|
19.25%
|
17.83%
|
-
|
Announcement Date
|
4/29/20
|
4/27/21
|
3/29/22
|
4/25/23
|
4/26/24
|
-
|
-
|
-
|
Last Close Price
20.62
CNY Average target price
28
CNY Spread / Average Target +35.77% Consensus |
1st Jan change
|
Capi.
|
---|
| -15.84% | 752M | | +11.84% | 27.79B | | -32.98% | 2.98B | | -15.97% | 2.52B | | +11.90% | 2.34B | | -1.11% | 1.91B | | -13.37% | 1.83B | | -7.78% | 1.39B | | -0.38% | 1.27B | | +4.01% | 1.13B |
Medical Supplies
|